http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S60163813-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db63c49866492070e86b92e498b3c0d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec742a19643f4a3e594b6739ccc385ca |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 |
| filingDate | 1984-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6a90c6408ce2a2632d5d92a22836cec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8538d928136c38f62299a7c1ca028e10 |
| publicationDate | 1985-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S60163813-A |
| titleOfInvention | Antiplasmin drug |
| abstract | PURPOSE: An antiplasmin drug, containing a metal salt of tranexamic acid as an essential component, having the antiplasmin action equal to that of the tranexamic acid and more prolonged action without side effects, and useful for hemorrhage and allergy, etc. n CONSTITUTION: An antiplasmin drug containing a metal salt of tranexamic acid, preferably calcium tranexamate as an esstenial component. The tranexamic acid has the following disadvantages; the antiphasmin action thereof vanishes in a short time after administration, and anaphylaxis and gastroenteric disorder appear as side effects. The tranexamate of this invention has the antiplasmin action equal to that of the tranexamic acid, higher absorbability and remains for a longer time than the tranexamic acid, and prolonged action without side effects such as the conventional gastroenteric disorder, anaphylaxis, etc. The drug is useful for dermatopathies, pharyngopathies, etc. caused by abnormal hemorrhage, allergy and inflammator lesion, etc. n COPYRIGHT: (C)1985,JPO&Japio |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0647616-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9400417-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5506264-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1132083-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0647616-A4 |
| priorityDate | 1984-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.